Authors
-
Hassan Abba
Hassan Abba is Head of R&D and Rare Disease Unit Architecture at AstraZeneca, leading the architectural vision for the company’s AI, data, and digital solutions. Prior to joining AstraZeneca, he spent his career driving large-scale digital transformation and IT strategy across Sky, Vodafone, and Royal Mail.
He holds a BEng in Software Engineering from the University of Manchester and an MBA from Henley Business School.
-
Naveed Shaikh
Naveed Shaikh is Senior Director of R&D Strategy and Enterprise Architecture at AstraZeneca, where he leads the R&D enterprise architecture function and helps shape the use of AI, data, and digital technologies across pharmaceutical R&D.
Prior to AstraZeneca, he spent more than a decade at Eli Lilly in senior technology and leadership roles. His experience working at the intersection of R&D, technology, and transformation informs this book, which he co-authored to offer a practical perspective on how pharmaceutical R&D organisations can turn advances in AI, data, and digital technologies into meaningful change.
He holds a BSc in Computer Science from the GIK Institute and a Master of Computing from the National University of Singapore.
Editor
Dr Richard Williams
Richard Williams has more than 30 years of experience in IT and business development. After founding, developing and selling a software development company, he specialised in IT and business consultancy, working at the intersection of business strategy and technology development. His work included advising organisations on mergers and acquisitions across a wide range of industry sectors.
Earlier in his career, Richard worked in academia, teaching and conducting research in the molecular biology of photosynthesis in higher plants.
He holds a BSc in Biological Sciences from the University of Birmingham, an MSc in Plant Systematics from the University of Reading and a PhD in Molecular Biology from the University of Warwick. He is a Fellow of the Linnean Society of London.